The Vectura board has recommended PMI's 165 pence-per-share offer to shareholdersRead More
The firm began trading on the market on Aug. 16 under its XXII symbol.Read More
Overseas products will soon require a prescription to enter Australia. Read More
The company is starting to catch up from pandemic-driven shipping delays. Read More
Law strikes balance between providing access to adults and minimizing underage appeal. Read More
The marketing veteran brings 25 years of experience developing strategies for renowned brands. Read More
The inhaled drug manufacturer’s directors describe the bid as “fair and reasonable.”Read More
The country’s phytosanitary supervision agency is satisfied with Malawi’s response to pest concerns. Read More
New division will identify and invest in companies in emerging industries.Read More
Chinese researchers suggest the pandemic started outside China. Read More
Recent Posts
- European Lawmakers to Vote on Outdoor Smoking Restrictions
- Supreme Court Won’t Hear Graphic Warning Challenge
- Lawmakers Urged to Reject Generational Ban
- Top Court to Hear Triton Vaping Case
- Spain Starts Consultation on Flavor Ban
- French Senate Approves Tobacco Tax Hikes
- Kyrgyzstan to Ban E-cigarettes
- Research: THR Plan May Save 400,000 Nigerian Lives
- U.S. E-Cigarette Sales Up Nearly 50 Percent
- Study: No Major Respiratory Symptoms Among Vapers
- ‘Pouch Nicotine Limits will Drive Users to Smoking’
- China Tobacco Deputy Head Expelled From Party
- Zyn Sued for Overcharging
- Imperial Releases Full-Year Results
- Surgeon General’s Report Addresses Disparities